OSCR

Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of <i>Acinetobacter radioresistens</i>.

Overview

Authors: Francesc X Guix1
ORCID iDs: Francesc X Guix
  1. Department of Bioengineering, Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), 08017 Barcelona, Spain
Journal: International journal of molecular sciences, volume 27, issue 8, article 3430
Dates: received 27 February 2026; accepted 8 April 2026; published online 11 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/ijms27083430 · PMID 42074073 · PMCID PMC13115908 · OpenAlex W7154183815
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), Alzheimer's / dementia (population), systems (subfield)
Methods: Statistics, Connectivity
Keywords: Alzheimer’s disease, metatranscriptomics, low-biomass microbiome, Kraken2, Bracken, edgeR, Acinetobacter, biofilms, amyloid cross-seeding, oral–brain axis
MeSH: Acinetobacter*, Alzheimer Disease*, Brain*, Transcriptome*, Female, Humans, Microbiota, Prefrontal Cortex (* major topic)
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Universitat Ramon Llull (2025-URL-Proj-007)
Citations: not cited yet (Europe PMC); 53 references in the paper

Abstract

Alzheimer’s disease (AD) is characterized by progressive cognitive decline and the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles. Beyond genetic and proteostatic mechanisms, infection- and dysbiosis-based models of AD have gained renewed attention, including the antimicrobial protection hypothesis, in which Aβ may participate in innate immune defense. Here, we reanalyzed ribosomal depleted (Ribo-Zero) RNA-seq data from dorsolateral prefrontal cortex (DLPFC) samples from the Mount Sinai Brain Bank cohort (GSE53697) to screen for non-human transcripts. Reads underwent quality control and adapter trimming, taxonomic classification with Kraken2, abundance re-estimation with Bracken, and differential abundance testing with edgeR. Across 17 samples (9 advanced AD and 8 controls), we detected low-biomass microbial signals, with Acinetobacter radioresistens showing enrichment in the AD group (FDR = 0.018). Several additional taxa showed suggestive group differences but did not remain significant after multiple testing correction, including Lactobacillus iners (FDR = 0.051). We also performed an exploratory in silico analysis of an A. radioresistens biofilm-associated protein homolog, identifying predicted amyloidogenic motifs and surface-exposed regions that may be relevant to cross-seeding hypotheses, although no mechanistic inference can be drawn without experimental validation. Given the technical challenges of inferring microbial signals from post-mortem brain RNA-seq data, including contamination risk, low microbial biomass, and overwhelming host background, these findings should be interpreted as hypothesis-generating and warrant orthogonal validation in larger, microbiome-aware cohorts.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

All sequencing data analyzed in this study are publicly available from the NCBI Gene Expression Omnibus under accession GSE53697 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53697) and associated SRA records. Analysis steps were performed using the Galaxy platform and standard open-source tools as described in the Methods.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 1 author, 10 keywords, 8 MeSH terms, 1 funder, 52 references.

Cite

This paper

Guix, F. X. (2026). Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of <i>Acinetobacter radioresistens</i>. International journal of molecular sciences, 27(8), 3430. https://doi.org/10.3390/ijms27083430

BibTeX

@article{guix2026metatranscriptomic,
author = {Guix, Francesc X},
title = {{Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of \<i\>Acinetobacter radioresistens\</i\>}},
journal = {International journal of molecular sciences},
year = {2026},
month = apr,
volume = {27},
number = {8},
pages = {3430},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {1422-0067},
doi = {10.3390/ijms27083430},
url = {https://doi.org/10.3390/ijms27083430},
pmid = {42074073},
pmcid = {PMC13115908}
}

RIS

TY - JOUR
AU - Guix, Francesc X
TI - Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of <i>Acinetobacter radioresistens</i>
T2 - International journal of molecular sciences
J2 - Int J Mol Sci
PY - 2026
DA - 2026/04/11
VL - 27
IS - 8
SP - 3430
SN - 1422-0067
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/ijms27083430
UR - https://doi.org/10.3390/ijms27083430
LA - en
ER -

CSL-JSON

{
"id": "10.3390/ijms27083430",
"type": "article-journal",
"title": "Metatranscriptomic Reanalysis of Alzheimer's Brains Identifies Low-Biomass Microbial Signals Including Enrichment of <i>Acinetobacter radioresistens</i>",
"container-title": "International journal of molecular sciences",
"author": [
{
"family": "Guix",
"given": "Francesc X"
}
],
"container-title-short": "Int J Mol Sci",
"volume": "27",
"issue": "8",
"page": "3430",
"DOI": "10.3390/ijms27083430",
"PMID": "42074073",
"PMCID": "PMC13115908",
"ISSN": "1422-0067",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/ijms27083430",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
11
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/brainsci14070677 [code]
Regional Differences in Microbial Infiltration of Brain Tissue from Alzheimer's Disease Patients and Control Individuals.
Journal: Brain sciences
In common: Alzheimer's / dementia, genetics / omics, 8 references
[2] doi:10.3389/fnagi.2022.1026260
High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer's and Parkinson's disease.
Journal: Frontiers in aging neuroscience
In common: Alzheimer's / dementia, genetics / omics, 7 references
[3] doi:10.1186/s13073-023-01155-w
The neuroimmune axis of Alzheimer's disease.
Journal: Genome medicine
In common: Alzheimer's / dementia, 6 references
[4] doi:10.1007/s12031-025-02469-7 [code]
Utilisation of Machine Learning Approaches Improves RNA-Seq Transcriptome Analyses in Alzheimer's Disease Brain.
Journal: Journal of molecular neuroscience : MN
In common: NCBI GEO GSE53697, Alzheimer's / dementia, genetics / omics, 2 references
[5] doi:10.1016/j.xcrm.2025.102520
Oxidized MIF is an Alzheimer's disease drug target relaying external risk factors to tau pathology.
Journal: Cell reports. Medicine
In common: Alzheimer's / dementia, 4 references
[6] doi:10.3389/fmicb.2022.875101
Integrated Microbiome and Host Transcriptome Profiles Link Parkinson's Disease to <i>Blautia</i> Genus: Evidence From Feces, Blood, and Brain.
Journal: Frontiers in microbiology
In common: genetics / omics, 4 references
[7] doi:10.1126/sciadv.aej4603
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice.
Journal: Science advances
In common: Alzheimer's / dementia, 4 references
[8] doi:10.3389/fnins.2025.1629830
&lt;i&gt;APOE4-APP&lt;/i&gt; interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer's disease.
Journal: Frontiers in neuroscience
In common: Alzheimer's / dementia, genetics / omics, 5 references
[9] doi:10.1016/j.xcrm.2024.101669
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease.
Journal: Cell reports. Medicine
In common: Alzheimer's / dementia, genetics / omics, 4 references
[10] doi:10.1093/brain/awag043
Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.
Journal: Brain : a journal of neurology
In common: Alzheimer's / dementia, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.